Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD

Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD

Yuzo Suzuki,1 Naoki Inui,1 Masato Karayama,1 Shiro Imokawa,2 Takashi Yamada,3 Koushi Yokomura,4 Kazuhiro Asada,5 Hideki Kusagaya,6 Yusuke Kaida,7 Hiroyuki Matsuda,8 Naoki Koshimizu,9 Mikio Toyoshima,10 Masafumi Masuda,11 Hiroshi Hayakawa,12 Hironao Hozumi,1 Kazuki Furuhashi,1 Noriyuki Enomoto,1 Tomo...

Full description

Bibliographic Details
Main Authors: Suzuki Y, Inui N, Karayama M, Imokawa S, Yamada T, Yokomura K, Asada K, Kusagaya H, Kaida Y, Matsuda H, Koshimizu N, Toyoshima M, Masuda M, Hayakawa H, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Suda T
Format: Article
Language:English
Published: Dove Medical Press 2019-08-01
Series:International Journal of COPD
Subjects:
Immune checkpoint inhibitor
Programmed death 1 (PD-1)
Non-small cell lung cancer (NSCLC)
Chronic obstructive pulmonary disease (COPD)
Online Access:https://www.dovepress.com/effect-of-pd-1-inhibitor-on-exhaled-nitric-oxide-and-pulmonary-functio-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/effect-of-pd-1-inhibitor-on-exhaled-nitric-oxide-and-pulmonary-functio-peer-reviewed-article-COPD

Similar Items